Healthy male volunteers, 18 to 45 years of age, inclusive. Healthy status is defined by absence of evidence of any active or chronic disease following a detailed medical and surgical history, a complete physical examination including vital signs, 12-lead ECG, hematology, blood chemistry, serology and urinalysis 
Body mass index (BMI) 18 to 30 kg/m2 inclusive 
Male subjects (whether surgically sterilized or not) with female partners of child-bearing potential must use two forms of contraception, one of which must be a barrier method, for the duration of the study and for 77 days after the last dose 

NCT01711801_inc_T1
Condition
Healthy
NCT01711801_inc_T2
Person
male
NCT01711801_inc_T3
Value
18 to 45 years , inclusive
NCT01711801_inc_T4
Person
age
NCT01711801_inc_T5
Negation
absence
NCT01711801_inc_T6
Observation
evidence of any active or chronic disease
NCT01711801_inc_T7
Observation
medical history
NCT01711801_inc_T8
Observation
surgical history
NCT01711801_inc_T9
Procedure
physical examination
NCT01711801_inc_T10
Procedure
vital signs
NCT01711801_inc_T11
Procedure
12-lead ECG
NCT01711801_inc_T12
Procedure
hematology
NCT01711801_inc_T13
Procedure
blood chemistry
NCT01711801_inc_T14
Procedure
serology
NCT01711801_inc_T15
Procedure
urinalysis
NCT01711801_inc_T16
Scope
absence of evidence of any active or chronic disease following a detailed medical and surgical history, a complete physical examination including vital signs, 12-lead ECG, hematology, blood chemistry, serology and urinalysis
NCT01711801_inc_T17
Measurement
Body mass index (BMI)
NCT01711801_inc_T18
Value
18 to 30 kg/m2 inclusive
NCT01711801_inc_T19
Person
Male
NCT01711801_inc_T20
Condition
surgically sterilized
NCT01711801_inc_T21
Condition
surgically sterilized
NCT01711801_inc_T22
Negation
not
NCT01711801_inc_T23
Person
female
NCT01711801_inc_T24
Condition
child-bearing potential
NCT01711801_inc_T25
Multiplier
two
NCT01711801_inc_T26
Device
forms of contraception
NCT01711801_inc_T28
Device
barrier method
NCT01711801_inc_T29
Temporal
for the duration of the study
NCT01711801_inc_T30
Temporal
for 77 days after the last dose
NCT01711801_inc_T31
Reference_point
the last dose
NCT01711801_inc_T32
Reference_point
the study